MDIC is an active member of the ENRICHMENT in Silico Clinical Trial Project (ENRICHMENT), which is led by principal investigators from FDA and Dassault Systèmes. In this capacity, MDIC is coordinating the formation of an Industry Advisory Council (IAC) for the project. The role of the IAC is to provide an industry perspective on new clinical trial methodology and tools being developed through ENRICHMENT including the practicality of implementing such approaches at a commercial level so as to ensure ENRICHMENT outputs are relevant to the medical device industry. More specifically, the IAC’s primary function shall be to provide guidance and input on the relevance and utility of the approaches to the regulatory process (rather than those related to technical aspects of the modeling and simulation). If you would like more information on the project please email us at